Verona Pharma's debt usage seems safe given sufficient short...

Verona Pharma's debt usage seems safe given sufficient short-term liquidity. Concerns over capital raise loom due to a lack of significant revenue and history of cash burn. Balance sheet isn't the only investment risk; identified warning signs also exist.